<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Novais FO</submitter><funding>NIAID NIH HHS</funding><pagination>1737-1745</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6178231</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>200(5)</volume><pubmed_abstract>Resolution of leishmaniasis depends upon parasite control and limiting inflammation. CD4+ Th1 cells are required to control parasites, whereas CD8+ T cells play a dual role: they promote Th1 cell differentiation but can also increase inflammation at the site of infection as a consequence of cytolysis. Although CD8+ T cells taken from leishmanial lesions are cytolytic, in this study, we showed that only a few CD8+ T cells produced IFN-?. Correspondingly, only low levels of IL-12 and/or IL-12 mRNA were present in lesions from infected mice, as well as patients. Addition of IL-12 increased IFN-? production by CD8+ T cells isolated from leishmanial lesions, suggesting that a lack of IL-12 at the site of infection limits IFN-? production by CD8+ T cells. To determine whether CD8+ T cells could promote resistance in vivo if IL-12 was present, we administered IL-12 to Leishmania-infected RAG mice reconstituted with CD8+ T cells. IL-12 treatment increased the ability of CD8+ T cells to make IFN-?, but CD8+ T cells still failed to control the parasites. Furthermore, despite the ability of CD8+ T cells to promote immunity to secondary infections, we also found that CD8+ T cells from immune mice were unable to control Leishmania in RAG mice. Taken together, these results indicate that lesional CD8+ T cells fail to make IFN-? because of a deficit in IL-12 but that, even with IL-12, CD8+ T cells are unable to control Leishmania in the absence of CD4+ T cells.</pubmed_abstract><journal>Journal of immunology (Baltimore, Md. : 1950)</journal><pubmed_title>CD8+ T Cells Lack Local Signals To Produce IFN-? in the Skin during Leishmania Infection.</pubmed_title><pmcid>PMC6178231</pmcid><funding_grant_id>R01 AI106842</funding_grant_id><pubmed_authors>Villareal DO</pubmed_authors><pubmed_authors>Wong AC</pubmed_authors><pubmed_authors>Scott P</pubmed_authors><pubmed_authors>Novais FO</pubmed_authors><pubmed_authors>Beiting DP</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD8+ T Cells Lack Local Signals To Produce IFN-? in the Skin during Leishmania Infection.</name><description>Resolution of leishmaniasis depends upon parasite control and limiting inflammation. CD4+ Th1 cells are required to control parasites, whereas CD8+ T cells play a dual role: they promote Th1 cell differentiation but can also increase inflammation at the site of infection as a consequence of cytolysis. Although CD8+ T cells taken from leishmanial lesions are cytolytic, in this study, we showed that only a few CD8+ T cells produced IFN-?. Correspondingly, only low levels of IL-12 and/or IL-12 mRNA were present in lesions from infected mice, as well as patients. Addition of IL-12 increased IFN-? production by CD8+ T cells isolated from leishmanial lesions, suggesting that a lack of IL-12 at the site of infection limits IFN-? production by CD8+ T cells. To determine whether CD8+ T cells could promote resistance in vivo if IL-12 was present, we administered IL-12 to Leishmania-infected RAG mice reconstituted with CD8+ T cells. IL-12 treatment increased the ability of CD8+ T cells to make IFN-?, but CD8+ T cells still failed to control the parasites. Furthermore, despite the ability of CD8+ T cells to promote immunity to secondary infections, we also found that CD8+ T cells from immune mice were unable to control Leishmania in RAG mice. Taken together, these results indicate that lesional CD8+ T cells fail to make IFN-? because of a deficit in IL-12 but that, even with IL-12, CD8+ T cells are unable to control Leishmania in the absence of CD4+ T cells.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2020-11-19T16:31:24Z</modification><creation>2019-06-06T20:16:55Z</creation></dates><accession>S-EPMC6178231</accession><cross_references><pubmed>29367210</pubmed><doi>10.4049/jimmunol.1701597</doi></cross_references></HashMap>